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Abstract 
Background: Clustered regularly interspaced short palindromic repeats interference (CRISPRi) is a recently devel-
oped powerful tool for gene regulation. In Escherichia coli, the type I CRISPR system expressed endogenously shall 
be easy for internal regulation without causing metabolic burden in compared with the widely used type II system, 
which expressed dCas9 as an additional plasmid.
Results: By knocking out cas3 and activating the expression of CRISPR-associated complex for antiviral defense 
(Cascade), we constructed a native CRISPRi system in E. coli. Downregulation of the target gene from 6 to 82% was 
demonstrated using green fluorescent protein. Regulation of the citrate synthase gene (gltA) in the TCA cycle affected 
host metabolism. The effect of metabolic flux regulation was demonstrated by the poly-3-hydroxbutyrate (PHB) accu-
mulation in vivo.
Conclusion: By regulating native gltA in E. coli using an engineered endogenous type I-E CRISPR system, we redi-
rected metabolic flux from the central metabolic pathway to the PHB synthesis pathway. This study demonstrated 
that the endogenous type I-E CRISPR-Cas system is an easy and effective method for regulating internal metabolic 
pathways, which is useful for product synthesis.
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Background
The ability to precisely manipulate expression level of the 
desired genes by repression or activation is important for 
understanding the complex functions of a gene network. 
RNA interference (RNAi) and engineered DNA-binding 
proteins are powerful technologies for gene regulation 
[1–3]. RNAi can be employed to knock down the expres-
sion of targeted genes. However, RNAi is limited to par-
ticular organisms that have the proper host machinery 
and can sometimes exhibit significant off-target effects 
and toxicity [3]. In addition, custom DNA-binding pro-
teins, such as transcription-activator-like effector (TALE) 
proteins or zinc finger, remain somewhat difficult and 
expensive to design, develop, and empirically test in the 
cellular context [1, 2].
The CRISPR-Cas system is an antivirus mechanism 
among Archaea and Bacteria [4–6]. Since the verifica-
tion of its function in cutting DNA and first use in gene 
editing [7, 8], this system has been widely used in various 
areas of research [9–13]. CRISPRi is one of these utilities. 
By mutating the DNase domain of Cas9 (class 2 type-II) 
or removing Cas3 (class 1 type-I) manually, the CRISPR 
system is inactivated for its DNA-cutting function, with 
DNA-binding function maintained [8, 11, 14]. This ena-
bles the system to bind to DNA without further cut-
ting it and thus impedes transcription, which facilitates 
the ability to regulate gene expression and is known as 
CRISPRi [11, 15]. Because of the advantages of CRISPRi-
a system requiring only Cas proteins and a single guide 
RNA (sgRNA) or CRISPR RNA (crRNA), with abundant 
targeting sites on the genome, being easy for targeting 
multi-genes with relatively low off-target potential and 
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showing reversible regulation effects [9, 11, 13, 16], it has 
been used in a variety of species.
Currently, class 2 type-II CRISPRi is the most widely 
used CRISPR system. Apart from sgRNA, this system 
need additionally express dCas9 (4  Kb), which requires 
the expression of a second vector in Escherichia coli [12]. 
Recently, two studies reported that endogenous class 1 
type I-E CRISPR system could be repurposed for gene 
regulation [16, 17]. Typically, in class 1 type I, the Cas-
cade mediates the maturation of crRNA and forms com-
plex with it, which then binds to the target site on DNA 
and recruits Cas3 to degrade the target DNA [7, 18–21]. 
By knocking out the cas3 gene in the genome, the Cas-
cade-crRNA complex retains the ability to bind to DNA 
[16, 17], functioning as a transcription regulation fac-
tor (Fig.  1). This system only requires the engineering 
of the strain and the expression of the CRISPR array for 
gene regulation purpose, and thus can be easily used for 
internal regulation without causing a metabolic burden. 
However, the endogenous type I-E CRISPR-Cas system 
has not been employed for biotechnological applications 
in E. coli.
Phosphoenolpyruvate, pyruvate, and acetyl-CoA are 
precursors for both the tricarboxylic acid cycle (TCA) 
and most synthetic pathways. Therefore, the produc-
tion of these chemicals competes with the TCA cycle. 
To improve biochemical production from a desired syn-
thetic pathway, genes encoding the enzymes for com-
peting pathways are often knocked out [22]. However, 
the deletion of genes associated with the TCA cycle has 
negative effects on cell growth and final cell density, and 
these genes are rarely employed as the deletion candidate 
target to increase the titer and yield of a target compound 
[23].
Here, after engineering the endogenous CRISPR sys-
tem, the metabolic effect of gltA regulation was evalu-
ated. PHB production in E. coli was chosen as a model 
to demonstrate the redirection of metabolic flux. Our 
Fig. 1 CRISPRi process used in this study. The crRNA was expressed on a plasmid and Cascade was activated for expression with the constitutive 
promoter J23119. Cascade mediates the maturation of crRNA and forms complex with the crRNA. The complex then binds to a target site to disturb 
transcription. RNAP indicates RNA polymerase, PAM indicates protospacer adjacent motif
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results showed that the endogenous type I-E CRISPR-
Cas system is an easy and effective method that can be 
used to regulate metabolic pathways.
Results
Construction and characterization of an endogenous 
CRISPRi system in E. coli
To construct the E. coli endogenous CRISPRi for gene 
regulation, we first disabled its DNA degradation func-
tion and maintained its DNA binding function by sub-
stituting cas3 and the promoter of the Cascade operon 
with the constitutive promoter J23119 in E. coli TOP10 
through homologous recombination (Additional file  1: 
Figure S1). The resulting strain TOP10Δcas3 was veri-
fied by PCR and agarose gel electrophoresis. Plasmid 
pcrRNA.BbsI was constructed and transformed into the 
strain to facilitate crRNA expression (Additional file  1: 
Figure S2).
Next, to verify the function of the system, a plasmid 
expressing GFP (PLYK) was co-transformed with crRNA 
expression vectors PGFP-Y into E. coli TOP10Δcas3 to 
construct series strains SGFP-Y (Y indicates 0, T1, T2, 
NT1, and NT2, which are spacer names; 0 indicates 
control, targeting no sites). Spacers were designed using 
a self-designed program to avoid potential off-target 
effects (Fig. 2a; Additional file 1: Figure S3). As demon-
strated in other studies [16, 17], targeting different sites 
of the gene can lead to different regulation effects. We 
observed a wide range of fluorescent repression (from 6 
to 82%) among the spacers (Fig.  2b). In the presence of 
l-arabinose, the spacers (T1, NT1) targeting the pro-
moter region of both strands showed strong repression 
effects, while T2 (targeting template strand) and NT2 
(targeting non-template strand) showed the lowest (6%) 
and highest (82%) repression levels, respectively.
Optimizing expression of crRNAs
The TCA cycle is one of the most important processes in 
central metabolism. It begins with the formation of citric 
acid from acetyl-coA and oxaloacetate, which is catalyzed 
by citrate synthase [24]. This process is irreversible and 
is the rate-limiting step in the TCA cycle. The regula-
tion of gltA, which encodes citrate synthase, will affect 
the TCA cycle, and thus regulate the metabolic flux of 
central metabolism. To optimize the expression of crR-
NAs in E. coli, we first constructed a low-copy plasmid 
(Paracr101) and medium-copy plasmid (Paracr15A) to 
express crRNAs with spacers targeting endogenous gltA 
in TOP10Δcas3, while a high copy plasmid was used for 
product synthesis. A spacer targeting the latter one of 
the two promoters of gltA was used to compare the two 
plasmids [25], which was designed to have tight repres-
sion effects. The strains containing the medium-copy 
plasmid (S15A-2) or low copy plasmid (S101-2) showed 
little growth variance when cultured in LB medium 
(Additional file 1: Figure S4). Next, both strains were cul-
tured in 50 mL M9 medium. As shown in Fig. 3, the two 
strains showed significant variance in growth. For S15A-
2, decreased growth was observed when l-arabinose was 
provided. For S101-2, growth was poor with or without 
l-arabinose. This indicated that the expression of crR-
NAs could not be harnessed by adding inducer using a 
low copy number plasmid when the strain was cultured 
in M9 medium. Therefore, the medium copy plasmid for 
crRNA expression was used in subsequent analyses. The 
spacers used were designed by the self-designed program 
as described above to avoid potential off-target effects 
(Fig. 4a).
Down‑regulation of gltA at different levels using 
endogenous CRISPRi
To investigate the regulation effects of targeting gltA at 
different sites, we constructed a series of strains S15A-N 
(N indicates 0, 1, 2, 3, 4) containing spacers of the cor-
responding number for fermentation (Fig. 4a). As shown 
in Fig. 4b, all strains showed repressed growth compared 
to the control, with strain S15A-2 showing strongest 
repression. For the accumulation of acetate, all strains 
Fig. 2 Verification of endogenous CRISPRi using GFP. a Spacers 
designed to target gfp on the plasmid. The red circles indicate the 
PAM sequence; red lines indicate the spacer. b Endogenous CRISPRi 
repressed gfp expression. The strains were cultured in a 96-well plate 
in 200 μL LB medium, with or without 0.2% l-arabinose. The error bars 
indicates the standard deviations of eight biological replicates. The 0 
indicates the control and T1, T2, NT1, and NT2 indicate the corre-
sponding spacer names
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produced more acetate than the control, with S15A-2 
producing the highest concentration of 8.85  g/L. When 
both promoters of gltA were targeted, targeting the lat-
ter strongly repressed the growth of the strains and 
increased the accumulation of acetate. The transcription 
of gltA among the strains was also analyzed by qRT-PCR. 
Method of relative quantification with standard curve 
was used (Additional file 1: Figure S5). The expression of 
gltA was down-regulated from 1.5- to 25-fold (Fig.  4c), 
with S15A-2 showing the strongest repression, which was 
in accordance with the growth results described above. 
As S15A-3 and S15A-4 showed little difference in growth, 
acetate accumulation and gltA transcription, we chose 
the spacer4 to construct strains in following studies.
Furthermore, we investigated the regulation effects 
of targeting gltA at different induction times by adding 
l-arabinose at 0, 12 and 24 h to strains S15A-X (X indi-
cates 0, 1, 2, 4). As shown in Table 1, all strains grew bet-
ter when l-arabinose was added at 12 or 24 h compared 
to addition at 0 h. Glycerol consumption was correlated 
with growth. All strains showed growth repression when 
l-arabinose was added at 0  h, including the control 
(Additional file 1: Figure S6). This may be because l-arab-
inose is toxic to these strains [26].
Demonstrating the redirection of metabolic flux using PHB 
accumulation
As proof of concept for the practical application of our 
regulation system, we introduced the PHB synthetic 
pathway to construct strain S15APHB-X. As shown in 
Additional file  1: Figure S7A, introduction of the PHB 
pathway eliminated the repression effect on growth, 
acetate accumulation among strains, which agrees with 
our previous results ([27], Additional file  1: Figure S7). 
Among the strains induced at 0 h, S15APHB-4 consumed 
Fig. 3 Comparison of the regulation effects between low-copy and 
medium-copy plasmids. Strains were cultured in 50 mL M9 medium 
containing 1% (v/v) glycerol and 0.2% (g/v) l-arabinose added at 0 h. 
The error bars indicate the standard deviations of three biological 
replicates
Fig. 4 Targeting at different sites on gltA using endogenous CRISPRi. a Spacers targeting gltA on the genome. The red circles indicate the PAM 
sequence and red lines indicate the spacer. P1 and P2 indicate the two promoters for native gltA. b Cell growth and acetate accumulation by S15A-
N. c Transcription variances among different strains with gltA targeted at different sites. The expression of S15A-0 was set to 100, while expression of 
other strains was calculated relative to this value. Strains were cultured in 50 mL M9 medium containing 1% (v/v) glycerol and 0.2% (g/v) l-arabinose 
added at 0 h. The error bars indicate the standard deviations of three biological replicates
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the largest amount of glycerol and showed the high-
est PHB production (19.6  g/L and 8.5%, respectively), 
in which the PHB content was 3.4-fold higher than in 
the control (Fig. 5; Additional file 1: Figure S7B). When 
strains were induced at different time, all strains except 
for the control showed decreased PHB accumulation 
when induced at 24 h compared to at 0 h. (Fig. 5).
Discussion
CRISPRi is a recently developed tool that can be used for 
transcription regulation [11]. Compared to the type II 
system, which was discovered in bacteria, type I is widely 
present in Bacteria and Achaea [28–30]. Numerous type 
I systems can be activated by deleting cas3, while others 
such as type I-A and type I-D can be used when Cas3 is 
mutated as dCas9 [16]. Using these systems, only crR-
NAs must be additionally expressed, which can be easy 
for regulation. Besides, most type I systems can recog-
nize more PAM types than type II, which could enlarge 
the available targeting sites for regulation. Then the Cas-
cade-bound R-loop is more stable than that of Cas9 [31, 
32], enabling greater control over regulation. Addition-
ally, dCas9 does not function properly in some Achaea, 
and thus an endogenous system is required for regulation 
purposes [33].
By using the engineered endogenous type I-E CRISPR 
system in E. coli, the effects in regulating GFP ranged 
from 6 to 82%. Spacers targeting the promoter region 
of both strands repressed GFP expression tightly, while 
targeting the non-promoter region on the non-template 
strand generally shows more repression effect than tar-
geting the other strand [11, 16, 17, 33]. Interestingly, 
while transcription occurred on the template strand, tar-
geting the non-template strand should cause a stronger 
repression effect. This might be related to the structural 
characteristics of RNA polymerase-DNA complex and 
Cascade-crRNA-DNA complex. The two promoters of 
native gltA were targeted using spacer1 and spacer2, 
respectively. However, only targeting the latter promoter 
had an significant repression effect on cell growth and 
transcription of gltA. This may be because when the for-
mer promoter was targeted, the latter could still function 
and thus was not tightly repressed.
The TCA is one of the most important processes in 
central metabolism. By regulating the expression of 
gltA using endogenous CRISPRi, the metabolism was 
redirected to PHB production. Before the introduc-
tion of PHB synthesis pathway, the repression level 
of gltA is nearly liner related to the growth and acetate 
Table 1 Cell growth, glycerol consumption and acetate accumulation at different induction times
a Strains were cultured in 50 mL M9 medium containing 1% (v/v) glycerol and 0.2% (g/v) l-arabinose added 0 or 24 h
b Data are shown as the average values and standard deviations of two biological replicates, samples were taken at 42 h
Content Induction time (h) Straina
S15A‑0 S15A‑1 S15A‑2 S15A‑4
ODb600 0 5.93 ± 0.68 6.45 ± 0.48 3.45 ± 0.04 5.22 ± 0.44
12 7.02 ± 0.15 6.63 ± 0.35 6.43 ± 0.10 6.53 ± 0.22
24 6.61 ± 0.13 6.82 ± 0.18 6.23 ± 0.12 6.94 ± 0.33
Glycerolb (g/L) 0 12.89 ± 0.00 12.89 ± 0.00 9.78 ± 0.68 12.52 ± 0.46
12 12.62 ± 0.31 12.26 ± 0.90 12.22 ± 0.12 12.60 ± 0.41
24 12.89 ± 0.00 12.89 ± 0.00 12.89 ± 0.00 12.89 ± 0.00
Acetateb (g/L) 0 2.65 ± 0.55 2.84 ± 0.22 3.81 ± 0.68 3.48 ± 0.52
12 3.28 ± 0.35 3.95 ± 0.50 3.36 ± 0.20 4.09 ± 0.21
24 3.40 ± 0.18 3.66 ± 0.22 3.22 ± 0.64 3.34 ± 0.42
Fig. 5 Production of PHB with gltA regulated using endogenous 
CRISPRi. Strains were cultured in 50 mL M9 medium containing 3% 
(v/v) glycerol. The inducer l-arabinose was added at 0 or 24 h at 
a concentration of 0.2% (g/v). The error bars indicate the standard 
deviations of three independent measurements
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accumulation of the strains, except for S15A-1. Recently, 
Soma et al. described a metabolic toggle switch with quo-
rum sensing system as a sensor that can control meta-
bolic flux from the TCA cycle towards the isopropanol 
synthetic pathway in appropriate time. The effects of 
switching gltA OFF on cell growth and acetate produc-
tion were investigated [34, 35]. The inhibited levels of 
the gltA OFF strains growth decreased with increasing 
induction time, which was in accordance with our results 
of downregulating gltA by endogenous CRISPR-Cas sys-
tem. However, after the introduction of PHB synthesis 
pathway, the variances on growth, acetate accumulation 
of strains containing different targeting sites were elimi-
nated. The isopropanol production titer of the resulting 
strains was threefold higher than in the control strain [34, 
35]. Our engineered E. coli produced three- to fourfold 
more PHB than the control strain.
Another common concern regarding the use of the 
CRISPR-Cas system is its off-target effects. A simple 
algorithm was developed to avoid potential off-target 
effects. In the regulation of GFP, spacer T1 was excluded 
by the program for 19 of its contiguous nucleotides and 
protospacer adjacent motif (PAM) are homologous to the 
genome (Additional file  1: Figure S8). To demonstrate 
the regulation effect of the promoter region, which no 
spacer was designed by the program, we designed spacer 
T1 manually and found that it off-targeted a pseudo 
gene with no known function in the genome. This fact 
proved that the GFP regulating result of this spacer was 
most likely caused by the regulation effect on the target 
site, but not a mixed result of targeting two sites on the 
genome, which proved that the result for spacer T1 could 
be used. In contrast to the well-studied type II system, for 
which numerous tools are available to predict off-target 
effects [36–40], few applicable tools exist for other types 
[41]. Then to decrease off-target phenomenon, the seed 
region of the spacer (with PAM) should be unique in the 
genome, which may be of vital importance for the base-
pairing of sgRNA or crRNA with DNA [11, 20, 32, 40–
45], or potential off-targeting sites of the spacer with no 
known functions should be confirmed.
Conclusions
In this study, we developed an endogenous type I-E 
CRIPSRi system in E. coli by knocking out cas3. Using 
this simple regulation strategy, we redirected metabolic 
flux by downregulating gltA in TCA. Redirection of the 
metabolic flux was demonstrated using PHB accumula-
tion, which increased by 3.4-fold compared to the con-
trol. This study demonstrated that the endogenous type 




All strains and plasmids used in this study are shown in 
Additional file 1: Tables S1, S2. To reconstruct the endog-
enous type I-E CRISPR-Cas system, E. coli Top10Δcas3 
was generated through recombination by knocking out 
cas3 and substituting the native promoter of the Cascade 
operon with J23119 [16].
To express the crRNAs, plasmid pcrRNA.ind were 
digested with KpnI and XhoI. The fragment was then 
ligated with annealed oligos BbsI-f and BbsI-r to form the 
plasmid pcrRNA.BbsI.
To construct plasmids Paracr15A and Paracr101 
expressing the crRNA, fragments of p15A-ori with 
spectinomycin (spcR) resistance (amplified from pLYK 
with cr15A-f and cr15A-r), pSC101-ori with spcR 
resistance (amplified from PHBS01, cr101-f, cr101-
r) were ligated to the backbone with araC CRISPR 
array (amplified from pcrRNA. BbsI using 15Acr-f, 
15Acr-r, and 101cr-f, 101cr-r, respectively), through 
Gibson-assembly.
To generate plasmids with the spacer targeting spe-
cific sites (PGFP-Y, Paracr15A-N, Paracr101-2), 1  μL 
pcrRNA.BbsI and 1  μL annealed spacer pairs were 
added to a 30 μL mixture of 0.5 μL T4 DNA ligase, 3 μL 
T4 DNA ligase buffer (10×), 0.5 μL T4 PNK, 1 μL BbsI, 
0.2  μL bovine serum albumin, and 22.8  μL ddH2O. The 
PCR conditions were as follows: 25 °C for 10  min and 
37  °C for 10  min for 15 cycles, 50  °C for 30  min, 80  °C 
for 30 min, and holding at 4 °C. The mixtures were then 
digested with 0.5 μL BbsI and 0.5 μL plasmid safe ATP-
dependent DNase at 37 °C for 30 min.
Growth conditions
For strain and plasmid construction, strains were cul-
tured in Luria–Bertani (LB) medium. For fermentation, 
strains were cultured in 50  mL M9 medium contain-
ing 2 g/L Amicase (Sigma, St. Louis, MO, USA), 0.2 g/L 
l-arabinose, and 1% (v/v) glycerol; 3% glycerol was used 
for PHB production. To maintain the plasmids, final con-
centrations of 100 μg/mL ampicillin, 50 μg/mL spectino-
mycin, and 25  μg/mL chloromycetin were added to the 
corresponding cultures.
Spacer design
All protospacers used in this study are listed in the 
Additional file  1: Table S3. Spacers were selected by a 
self-designed algorithm considering GC content, poly-
T structure, and seed (7–12 nucleotides in addition to 
PAM) together with PAM [17, 40] not homologous to 
other parts of the genome. The PAMs of AGG, ATG, and 
AAG, which had been proved to work were used.
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Fluorescence detection
Strains were pre-cultured in 5  mL LB medium in tubes 
overnight at 37 °C with shaking at 250 rpm. Next, 4 μL of 
the culture was added to 200 μL LB medium in a 96-well 
plate containing l-arabinose and the appropriate antibi-
otics. The plate was cultured and absorbance was meas-
ured using a microplate reader (Synergy HT, BioTek, 
Winooski, VT, USA) at 37 °C at a medium shaking speed 
to detect the fluorescence and cell density.
qRT‑PCR analysis
Fragments of gltA and 16S rRNA amplified from TOP10, 
together with fragments containing AmpR and the 
pBR322 origin of replication were  ligated through Gib-
son-assembly to construct plasmids PGLTA and P16S, 
respectively.
Total mRNA was extracted using an RNAprep Cul-
ture Cell/Bacterial Kit (Tiangen, Beijing, China). Next, 
2  μL total mRNA was used for reverse transcription 
(cDNA synthesis) using the Primer Script RT reagent 
Kit with gRNA Eraser (TaKaRa, Shiga, Japan), and ran-
dom primers were used according to the manufacturer 
instructions. Processes involving RNA and cDNA were 
conducted on ice except for reaction. The extracted 
RNA and cDNA were stored at −80 °C for no more than 
2 weeks after density measurement.
Plasmid PGLTA and P16S were serially diluted to 102, 
104, 106, 107, and 108-fold (concentrations of 10−2, 10−4, 
10−6, 10−7, 10−8, respectively) to construct the stand-
ard curves for the target (gltA) and internal control (16S). 
SYBR Premix Ex Taq™II (TaKaRa) was used for qPCR. The 
25-μL reaction mixture contained 12.5  μL enzyme mix, 
10 μL H2O, 0.5 μL ROX II, 0.5 μL forward primer (10 mM), 
0.5 μL reverse primer (10 mM), and 1 μL sample cDNA or 
standard plasmid DNA. Primers RT-16S-for, RT-16S-rev, 
RT-GLTA-for, and RT-GLTA-rev were used to quantify 
gltA and 16S in the samples and standard, respectively. The 
primers were designed using Primer6 and the specifici-
ties were verified by additional qPCR. Three parallel reac-
tions were conducted for each sample or standard. The 
reaction program was conducted using Quant Studio 3 
(Thermo Fisher Scientific, Waltham, MA, USA) following 
the SYBR Premix Ex Taq™ II instructions. The specificity 
of qPCR was verified by melt-curve analysis of the ampli-
fied sequence. The results were analyzed using QuantStu-
dio™ Design and Analysis software 1.3.1 automatically, and 
the exported results were analyzed using OriginPro 9.0 
(Originlab, Northampton, MA, USA) [46, 47].
Analysis of substrates and products
Biomass was measured as the optical density value at 
600  nm using a spectrophotometer (Shimazu, Japan). 
To analyze acetate and glycerol, 1  mL of the culture 
was centrifuged at 12,000 rpm for 2  min; the superna-
tant was then filtrated through a 0.22-μm syringe filter 
and quantitatively examined by using high-performance 
liquid chromatography (HPLC) (Shimadzu, Japan) 
equipped with a refractive index detector (RID-10A) 
(Shimadzu, Japan) and an Aminex HPX-87H ion exclu-
sion column (Bio-Rad, USA). A 5  mM H2SO4 solution 
was used as a mobile phase at a flow rate of 0.6 mL/min 
to the column at 65  °C. Standards were prepared for 
acetate and glycerol and calibration curves were created. 
The detection sensitivity was 0.1  μg compounds per 
HPLC assay (10  μL). The detection limit for the extra-
cellular metabolites and carbon sources was 10  mg/L 
[48]. PHB was quantitatively analyzed using gas chro-
matography. Briefly, liquid cultures were centrifuged 
at 10,000g for 10 min, and then the cells were washed 
twice in saline and lyophilized overnight. About 15 mg 
lyophilized cell mass was mixed with 1 mL chloroform 
and 1 mL methanol containing 15% (v/v) sulfuric acid. 
The methanolysis was performed at 100 °C for 1 h in an 
oil bath. Then 1 mL water was added to the mixture and 
mixed thoroughly for 20  s. After phase separation, the 
heavier chloroform phase was transferred to another 
new vial for GC analysis. The PHB content was defined 
as the percentage ratio of the PHB concentration to bio-
mass [27, 49].
Genes and plasmids sequence
Genes and genome sequences were downloaded from 
NCBI [50].
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